Guevara-López U, Covarrubias-Gómez A, Ochoa-Carrillo FJ, Fernández-Orozco A, Bernal-Sahagún F

Idioma: Español
Referencias bibliográficas: 50
Paginas: 381-396
Archivo PDF: 149.82 Kb.

RESUMEN

El dolor por cáncer es un problema frecuente en nuestro medio, se presenta en 80 a 90 % de los pacientes y en aproximadamente 90 % de ellos se resuelve con medidas relativamente sencillas. No obstante, aproximadamente 40 % de los pacientes se encuentra insatisfecho con el médico o la enfermera respecto al manejo de su dolor. Por tal motivo, se convocó a un grupo de consenso con la finalidad de generar parámetros de práctica clínica fundamentados en la evidencia publicada y en la opinión de los expertos. Este grupo estuvo integrado por 31 médicos líderes de opinión es este campo, quienes con base en 599 documentos emitieron esta serie de recomendaciones, identificadas cada una según su nivel de evidencia.

REFERENCIAS (EN ESTE ARTÍCULO)

1. 1.World Health Organization. The world health report 2003: shaping the future. Geneva: WHO Press;2003.

2. 2.World Health Organization. World Health Report 2000. Geneva: WHO Press;2000.

3. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001;2:533-543.

4. Instituto Nacional de Estadística, Geografía e Informática (INEGI). Estadísticas de mortalidad. México;2005 (www.inegi.gob.mx)

5. Jacox A, Carr DB, Payne R. New clinical-practice guidelines for the management of pain in patients with cancer. N Engl J Med 1994;390:651-655.

6. Bruera E, Kim HN. Cancer pain. JAMA 2003;290:2476-2479.

7. American Pain Society Quality of Care Committee. Quality improvement guidelines for the treatment of acute pain and cancer pain. JAMA 1995;274:1874-1880.

8. Careceni A, Portenoy RK. An international survey of cancer pain characteristics and syndromes. Pain 1999;82:263-274.

9. Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994;330:592-596.

10. Ashburn MA, Caplan RA, Connis RT, et al. Practice guidelines for acute pain management in the perioperative setting: An updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology 2004;100:1573-1581.

11. 11.Canadian Task Force on the Periodic Health Examination. The periodic health examination. Can Med Assoc J 1979;121:1193-1254.

12. 12.Woolf SH, Battista RN, Anderson GM, et al. Assessing the clinical effectiveness of preventative maneuvers: analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. J Clin Epidemiol 1990;43:891-905.

13. 13.US Preventive Services Task Force. Screening for adolescent idiopathic scoliosis: review article. JAMA 1993;269:2667-2772.

14. 14.US Preventive Services Task Force Ratings: Strength of Recommendations and Quality of Evidence. Guide to Clinical Preventive Services, 3rd ed. Periodic Updates, 2000-2003. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/3rduspstf/ratings.htm

15. Guyatt GH, Sackett DL, Sinclair JC, et al. Users’ guides to the medical literature: IX: a method for grading health care recommendations. JAMA 1995;274:1800-1804.

16. 16.Ferrante FM, Bedder M, Caplan RA, et al. Practice guidelines for cancer pain management: A report by the American Society of Anesthesiologists Task Force on Pain Management, Cancer Pain Section. Anesthesiology 1996;84:1243-1257.

17. Jost LM; ESMO Guidelines Task Force. ESMO Minimum Clinical Recommendations for the management of cancer pain. Ann Oncol 2005;16:i83-i85.

18. Benedetti C, Brock C, Cleeland C, Coyle N, et al. National Comprehensive Cancer Network. NCCN Practice Guidelines for Cancer Pain. Oncology 2000;14:135-150.

19. Frampton M. Experience assessment and management of pain in people with dementia. Age Aging 2003;32:248-251.

20. Caraceni A, Brunelli C, Martini C, et al. Cancer Pain Assessment in Clinical Trials. A Review of the Literature (1999–2002). J Pain Symptom Manage 2005;29:507-519.

21. Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS. When is cancer pain mild, moderate, or severe? Grading pain severity by its interference with function. Pain 1995;61:277-284.

22. Paul SM, Zelman DC, Smith M, Miaskowski C. Categorizing the severity of cancer pain: further exploration of the establishment of cutpoints. Pain 2005;113:37-44.

23. 23.Tong D, Gillick L, Hendrickson FR. The palliation of symptomatic osseous metastases: final results of the study by the Radiation Therapy Oncology Group. Cancer 1982;50:893-899.

24. 24.World Health Organization. Cancer pain relief and palliative care. Geneva: WHO 1990.

25. 25.Ventafridda V, Tamburini M, Caraceni A, et al. A validation study of the WHO method for cancer pain relief. Cancer 1987;59:850-856.

26. Zech DFJ, Grond S, Lynch J, et al. Validation of World Health Organization guidelines for cancer pain relief: a 10-year prospective study. Pain 1995;63:65-76.

27. Mercadante S. Pain treatment and outcome in advanced cancer patients followed at home. Cancer 1999;85:1849-1858.

28. Mercadante S. The use of anti-inflammatory drugs in cancer pain. Cancer Treat Rev 2001;27:51-61.

29. McNicol E, Strassels SA, Goudas L, et al. NSAIDS or paracetamol, alone or combined with opioids, for cancer pain. J Clin Pain 2004;22:1975-1992.

30. Eisemberg E, Berkey CS, Carr DB, et al. Efficacy and safety of nonsteroidal antinflammatory drugs for cancer pain: a meta-analysis. J Clin Oncol 1994;12:2756-2765.

31. Launay-Vacher V, Karie S, Fau JB, et al. Treatment of pain in patients with renal insufficiency: The World Health Organization Three-Step Ladder Adapted. J Pain 2005;6:137-148.

32. Guevara-López U, Covarrubias-Gómez A, DeLille-Fuentes R, et al. Parámetros de práctica para el manejo del dolor agudo perioperatorio. Cir Ciruj 2005;73:223-232.

33. Guevara-López U, Covarrubias-Gómez A, Hernández-Ortiz A. Parámetros de práctica para el manejo del dolor agudo. Cir Ciruj 2005;73:393-404.

34. Cherny NI. The pharmacological management of cancer pain. Eur J Cancer 2001;37:S265-278.

35. Kalso E, Allan L, Dellemijn PLI, et al. Recommendations for using of opioids in chronic non-cancer pain. Eur J Pain 2003;7:381-386.

36. 36.Wiffen PJ, Edwards JE, Barden J, McQuay HJM. Oral morphine for cancer pain. Cochrane System Rev 2005;4:CD.

37. Nicholson AB. Methadone for cancer pain. Cochrane System Rev 2005;4:CD003971.

38. Portenoy R, Lesage P. Management of cancer pain. Lancet 1999; 353:1695-1700.

39. Bell RF, Eccleston C, Kalso E. Ketamine as adjuvant to opioids for cancer pain: A qualitative systematic review. J Pain Symptom Manage 2003;26:867-875.

40. Ross JR, Saunders Y, Edmons PM, et al. Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer. BMJ 2003;327:469-474.

41. Small EJ, Smith MR, Seaman JJ, Petrone S, Kowalski MO. Combined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodium for the palliation of bone pain in men with metastatic prostate cancer. J Clin Oncol 2003;21:4277-4284.

42. 42.Wardley A, Davidson N, Barrett-Lee P, et al. Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bisphosphonate administration. Br J Cancer 2005;92:1869-1876.

43. Body JJ, Diel IJ, Bell R, Pecherstorfer M, et al. Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer. Pain 2004;111:306-312.

44. Roqué M, Martinez MJ, Alonso P, et al. Radioisótopos para el dolor óseo metastásico. En: Cochrane Library plus en español. Oxford: Update Software.

45. Ballantyne JC, Carr DB, Berkey CS, et al. Comparative efficacy of epidural, subarachnoid, and intracerebroventricular opioids in patients with pain due to cancer. Reg Anesth 1996;21:542-556.

46. Smith TJ, Staats PS, Deer T, et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol 2002;20:4040-4049.

47. Rauck RL, Cherry D, Boyer MF, et al. Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain. J Pain 2003;4:441-447.

48. Eisenberg E, Carr DB, Chalmers TC. Neurolytic celiac plexus block for treatment of cancer pain: a meta-analysis. Anesth Analg 1995;80:290-295.

49. Eisenberg DM, Kessler RC, Foster C. Unconventional medicine in the United States: prevalence, costs, and patterns of use. N Engl J Med 1993;328:246-252.

50. Covarrubias-Gómez A, Nuche-Cabrera E, Téllez-Isaías M. ¿Qué se autoadministra su paciente?: interacciones farmacológicas de la medicina herbal. Rev Mex Anest 2005;28:32-42.